Stephen Wikel

Senior Scientist at US BIOLOGIC

Dr. Wikel received a Ph.D. from the University of Saskatchewan and went on to serve as a staff fellow at the Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, as well as Professor and Acting Chair, Department of Immunology, School of Medicine, University of Connecticut. He subsequently served as Professor of Pathology, University of Texas Medical Branch and Senior Scientist at the Center for Tropical Diseases and Center for Biodefense and Emerging Infectious Diseases, Galveston National Laboratory.

In 2011, Dr. Wikel was appointed Senior Associate Dean, Professor and Chairman, Department of Medical Sciences, and St. Vincent’s Medical Center Endowed Chair, School of Medicine, Quinnipiac University, as one of four deans to establish a new school.

Dr. Wikel has led worldwide research collaborations in tick physiology and genetic discovery research, as well as host immunological responses and vector countermeasures to host defenses at the arthropod vector-host-pathogen interface; the role of those interactions on blood feeding and pathogen transmission; and, development of novel immune-based anti-vector and pathogen transmission-blocking control strategies.

Dr. Wikel has ninety-one peer-reviewed publications and sixteen invited review and book chapters on these topics. He has been a featured speaker for seventy-five national and international symposia. Dr. Wikel received extramural research support for his program from the National Institutes of Health, U.S. Army Medical Research and Materiel Command, Centers for Disease Control and Prevention, U.S. Department of Agriculture and industry. He has extensive service experience as a member of advisory panels, research study sections, editorial boards, and academic institution administration.


Org chart


Teams


Offices

This person is not in any offices


US BIOLOGIC

US BIOLOGIC is a social innovation company that "Delivers Disease Prevention®”. The company’s proprietary oral-delivery platform is changing global disease prevention, allowing safe, effective, and cost-efficient delivery of a variety of preventative therapeutics (vaccine and antimicrobial) to wildlife, companion animals, food animals, and humans.


Industries

Employees

11-50

Links